FIELD: organic chemistry, medicine, pharmacy.
SUBSTANCE: invention relates to a crystalline form of the compound (S)-2-ethoxy-3-[4-(2-{4-methanesulfonyloxyphenyl}ethoxy)phenyl]propanoic acid represented by the formula (I): . This compound can be used in treatment of states associated with disturbance metabolism, in particular, states associated with insulin-resistance syndrome. Crystalline form of compound of the formula (I) promotes to the simplified preparing and homogenicity of the preparation.
EFFECT: improved and valuable medicinal and pharmaceutical properties of compounds.
3 cl, 1 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
GROUND FORM OF (S)-2-ETHOXY-3-[4-(2-{4-METANESULFONYLOXYPHENYL}ETHOXY)PHENYL]PROPANOIC ACID | 2000 |
|
RU2248966C2 |
C-MET/HGFR INHIBITOR POLYMORPHS | 2006 |
|
RU2387650C2 |
NOVEL THIENO-PYRIMIDINE DERIVATIVES, METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | 2014 |
|
RU2605403C2 |
NEW BICYCLIC DERIVATIVES, METHOD FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | 2016 |
|
RU2760554C1 |
METHOD OF PRODUCING (4S)-4-(4-CYANO-2-METHOXYPHENYL)-5-ETHOXY-2,8-DIMETHYL-1,4-DIHYDRO-1,6-NAPHTHYRIDINE-3-CARBOXAMIDE AND ISOLATING (4S)-4-(4-CYANO-2-METHOXYPHENYL)-5-ETHOXY-2,8-DIMETHYL-1,4-DIHYDRO-1,6-NAPHTHYRIDINE-3-CARBOXAMIDE BY ELECTROCHEMICAL METHODS | 2016 |
|
RU2715226C2 |
(2S,4R)-5-(5'-CHLORO-2'-FLUOROBIPHENYL-4-YL)-4-(ETHOXYOXALYLAMINO)-2-HYDROXYMETHYL-2-METHYLPENTANOIC ACID | 2016 |
|
RU2726623C2 |
NOVEL AMMONIUM DERIVATIVES, A METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | 2016 |
|
RU2743098C2 |
METHOD OF PRODUCING (4S)-4-(4-CYANO-2-METHOXYPHENYL)-5-ETHOXY-2,8-DIMETHYL-1-4-DIHYDRO-1,6-NAPHTHYRIDINE-3-CARBOXAMIDE AND ITS PURIFICATION FOR USE AS PHARMACEUTICAL ACTIVE INGREDIENT | 2015 |
|
RU2729998C2 |
METHODS FOR PREPARATION OF (S)-1-(3-ETHOXY-4-METHOXYPHENYL)-2-METHANESULFONYLETHYLAMINE | 2013 |
|
RU2632875C2 |
CRYSTALLINE FUMARATE SALT OF (S)-[3,4-DIFLUORO-2-(2-FLUORO-4-IODOPHENYLAMINO)PHENYL][3-HYDROXY-3-(PIPERIDINE-2-YL)AZETIDINE-1-YL]METHANONE | 2016 |
|
RU2762181C2 |
Authors
Dates
2006-01-27—Published
2000-11-29—Filed